Inventor
PARK JOHN
KR43 patents
⚠️ This page may combine multiple inventors who share the name “PARK JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABLYNX NV
5 patentsUS11208476B2Dec 28, 2021
Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP
ABLYNX NV12 citations83
US11840566B2Dec 12, 2023
Methods of treating asthma with polypeptides targeting IL-13 and TSLP
ABLYNX NV1 citations70
US12492248B2Dec 9, 2025
Methods of treatment utilizing polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP
ABLYNX NV0 citations59
US12384840B2Aug 12, 2025
Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP
ABLYNX NV0 citations59
US12509522B2Dec 30, 2025
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40L
ABLYNX NV0 citations47
AOD HOLDINGS LLC
4 patentsBRIDGEWAVE COMMUNICATIONS INC
2 patentsALLEGRO PHARMACEUTICALS LLC
2 patentsALLEGRO PHARMACEUTICALS INC
2 patentsUS10307460B2Jun 4, 2019
Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites
ALLEGRO PHARMACEUTICALS INC6 citations81
US9872886B2Jan 23, 2018
Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites
ALLEGRO PHARMACEUTICALS INC8 citations81